跳到正文
原文
Adam Feuerstein ✡️· @adamfeuerstein · X·· 15 天前精选AI 评分71
AI 导读

据FDA的AEMS数据库,又一名服用Neurocrine的Vykat的Prader-Willi综合征患者死亡,这是该药获批以来报告的第8例患者死亡。与其他病例一样,肿胀和高血糖被列为促成因素。

推荐理由

FDA不良事件数据库显示Vykat相关死亡增至8例,且均涉及肿胀与高血糖,为用药风险提供可核查信号。

正文

Another Prader Willi patient prescribed Neurocrine's $NBIX Vykat has died, according to the FDA's AEMS database.

That's the eighth patient death reported since the drug was approved. Like the other cases, "swelling" and hyperglycemia were listed as contributing factors.

来源:Adam Feuerstein ✡️ · x.com